AI Assistant
Blog
Pricing
Log In
Sign Up
Peptidomimetics designed to bind to RAS effector domain are promising cancer therapeutic compounds
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
